Found 24 results
Author Title [ Type(Desc)] Year
Filters: Author is [...]  [Clear All Filters]
Journal Article
B. S. Graham, McElrath, M. J., Connor, R. I., Schwartz, D. H., Gorse, G. J., Keefer, M. C., Mulligan, M. J., Matthews, T. J., Wolinsky, S. M., Montefiori, D. C., Vermund, S. H., Lambert, J. S., Corey, L., Belshe, R. B., Dolin, R., Wright, P. F., Korber, B. T., Wolff, M. C., and Fast, P., Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines, J Infec Dis, vol. 177, pp. 310-319, 1998.
V. Karantalis, DiFede, D., Gerstenblith, G., Pham, S., Symes, J., Zambrano, J., Fishman, J., Pattany, P., McNiece, I., Conte, J., ,, Mendizabal, A., Karas, T., Byrnes, J., Lowery, M., Heldman, A., and Hare, J., Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting [..], Circ Res, vol. 114, pp. 1302-1310, 2014.
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., ,, Stoll-Johnson, L., and Ketter, N., Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials, PLoS ONE, vol. 3, p. e2043, 2008.
J. Ledgerwood, DeZure, A., Stanley, D., Novik, L., Enama, M., Berkowitz, N., Hu, Z., Joshi, G., Ploquin, A., Sitar, S., Gordon, I., Plummer, S., Holman, L., ,, Mascola, J., Koup, R., Sullivan, N., and Graham, B., Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report, N Engl J Med, 2014.
J. M. Hare, Fishman, J. E., Gerstenblith, G., Velazquez, D. L. Difede, Zambrano, J. P., V, S., Tracy, M., Ghersin, E., Johnston, P., ,, Davis-Sproul, J., Schulman, I., Byrnes, J., Mendizabal, A., Lowery, M., ,, McNiece, I. K., and Heldman, A. W., Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial, JAMA, vol. 308, pp. 2369-2379, 2012.
V. Suncion, Ghersin, E., Fishman, J., Zambrano, J., Karantalis, V., Mandel, N., Nelson, K., Gerstenblith, G., D Velazquez, D. F., Breton, E., Sitammagari, K., ,, Mendizabal, A., Tracy, M., Da Silva, J., McNiece, I., Lardo, A., George, R., Hare, J., and Heldman, A., Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?: An Analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) Randomized Trial, Circ Res, vol. 114, pp. 1292-1301, 2014.
L. Kottyan, Davis, B., Sherrill, J., Liu, K., Rochman, M., Kaufman, K., Weirauch, M., Vaughn, S., Lazaro, S., Rupert, A., Kohram, M., Stucke, E., Kemme, K., ,, Lindblad, R., Sampson, H., Mukkada, V., Putnam, P., Abonia, J., Martin, L., Harley, J., and Rothenberg, M., Genome-Wide Association Analysis of Eosinophilic Esophagitis Provides Insight Into the Tissue Specificity of This Allergic Disease, Nat Genet, vol. 46, pp. 895-900, 2014.
L. Baden, Liu, J., Li, H., Johnson, J., Walsh, S., Kleinjan, J., Engelson, B., Peter, L., Abbink, P., ,, Golden, K., Viani, K., Stachler, M., Chen, B., ,, Wolff, M., Loblein, H., Seaman, M., Dolin, R., and Barouch, D., Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans, J Infect Dis, vol. 211, pp. 518-528, 2015.
A. Balamurugan, Naziruddin, B., Lockridge, A., Tiwari, M., Loganathan, G., Takita, M., Matsumoto, S., Papas, K., Trieger, M., Rainis, H., Kin, T., Kay, T., Wease, S., Messinger, S., ,, Maffi, P., Secchi, A., Berney, T., O'Connell, P., Hering, B., and Barton, F. B., Islet Product Characteristics and Factors Related to Successful Human Islet Transplantation From the Collaborative Islet Transplant Registry (CITR) 1999-2010, Am J Transplant, vol. 14, pp. 2595-2606, 2014.
S. Mehendale, van Lunzen, J., Clumeck, N., Rockstroh, J., Vets, E., Johnson, P. R., Anklesaria, P., Barin, B., Boaz, M., Kochhar, S., Lehrman, J., Schmidt, C., Peeters, M., Schwarze-Zander, C., Kabamba, K., Glaunsinger, T., Sahay, S., Thakar, M., ,, and Heald, A., A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C Adeno-Associated Virus Vaccine, AIDS Research and Human Retroviruses, vol. 24, pp. 873-880, 2008.
M. Keefer, Gilmour, J., Hayes, P., Gill, D., Kopycinski, J., Cheeseman, H., Cashin-Cox, M., Naarding, M., Clark, L., Fernandez, N., Bunce, C., Hay, C., Welsh, S., ,, Loughran, K., Barin, B., Cormier, E., Cox, J. H., Fast, P., and Excler, J., A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults, PLoS One, vol. 7, p. e41936, 2012.
G. Omosa-Manyonyi, Mpendo, J., Ruzagira, E., Kilembe, W., Chomba, E., Roman, F., Bourguignon, P., Koutsoukos, M., Collard, A., Voss, G., Laufer, D., Stevens, G., Hayes, P., Clark, L., Cormier, E., Dally, L., Barin, B., ,, Gilmour, J., Cox, J., Fast, P., and Priddy, F., A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults, PLoS One, vol. 10, p. e0125954, 2015.
B. Leyland-Jones, Ambrosone, C., Bartlett, J., Ellis, M., Enos, R., Raji, A., Pins, M., Zujewski, J., Hewitt, S., Forbes, J., Abramovitz, M., Braga, S., Cardoso, F., Harbeck, N., Denkert, C., Jewell, S., Group, B. Internatio, and , Recommendations for Collection and Handling of Specimens from Group Breast Cancer Clinical Trials, J Clin Oncol, vol. 26, pp. 5638-5644, 2008.
M. L. Robb, Rerks-Ngarm, S., Nitayaphan, S., Pitisuttithum, P., Kaewkungwal, J., Kunasol, P., Khamboonruang, C., Thongcharoen, P., Morgan, P., Benenson, M., Paris, R. M., Chiu, J., Adams, E., Francis, D., ,, Stablein, D., Michael, N., and Kim, J. H., Risk Behaviour and Time as Covariates for Efficacy of the HIV Vaccine Regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A Post-Hoc Analysis of the Thai Phase 3 Efficacy Trial RV 144, Lancet Inf Dis, vol. 12, pp. 531-537, 2012.
B. Rivoire, Groathouse, N., TerLouw, S., K Neupane, D., Ranjit, C., B Sapkota, R., Khadge, S., Kunwar, C., Macdonald, M., Hawksworth, R., Thapa, M., Hagge, D., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., ,, Sizemore, C., and Brennan, P., Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study, PLOS Neglected Tropical Diseases, vol. 8, p. e2811, 2014.
H. Kibuuka, Berkowitz, N., Millard, M., Enama, M., Tindikahwa, A., Sekiziyivu, A., Costner, P., Sitar, S., Glover, D., Hu, Z., Joshi, G., Stanley, D., Kunchai, M., Eller, L., Bailer, R., Koup, R., Nabel, G., ,, Robb, M., and Ledgerwood, J., Safety and Immunogenicity of Ebola Virus and Marburg Virus Glycoprotein DNA Vaccines Assessed Separately and Concomitantly in Healthy Ugandan Adults: A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Clinical Trial, Lancet, vol. 385, no. 9977, pp. 1545-1554, 2015.
J. W, FN, N., O, A., G, O. Manyonyi, J, B., A, N., F, B., K, B., H, O., S, W., L, M., W, W., J, O., M, O., J, I., J, N. - A., C, K., ,, Smith, C., Barin, B., Dally, L., ,, and Kaleebu, P., Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa, Vaccine, vol. 26, pp. 2788-2795, 2008.
J. W, FN, N., O, A., G, O. Manyonyi, J, B., A, N., F, B., K, B., H, O., S, W., L, M., W, W., J, O., M, O., J, I., J, N. - A., C, K., ,, Smith, C., Barin, B., Dally, L., ,, and Kaleebu, P., Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa, Vaccine, vol. 26, pp. 2788-2795, 2008.
P. Pitisuttithum, Rerks-Ngarm, S., Bussaratid, V., Dhitavat, J., Maekanantawat, W., Pungpak, S., Suntharasamai, P., Vanijanonta, S., Nitayapan, S., Kaewkungwal, J., Benenson, M., Morgan, P., O'Connell, R., Berenberg, J., Francis, D., ,, Stablein, D., and , Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand, PLoS One, vol. 6, p. e27837, 2011.
P. Pitisuttithum, Rerks-Ngarm, S., Bussaratid, V., Dhitavat, J., Maekanantawat, W., Pungpak, S., Suntharasamai, P., Vanijanonta, S., Nitayapan, S., Kaewkungwal, J., Benenson, M., Morgan, P., O'Connell, R., Berenberg, J., Francis, D., ,, Stablein, D., and , Safety and Reactogenicity of Canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E Vaccination in an Efficacy Trial in Thailand, PLoS One, vol. 6, p. e27837, 2011.
E. Chew, Clemons, T. E., SanGiovanni, J. P., Danis, R., Ferris, F. 3rd, Elman, M., Antoszyk, A., Ruby, A., Orth, D., Bressler, S., Fish, G., Hubbard, G., Klein, M., Chandra, S., ,, and Sperduto, R., Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3, JAMA Ophthalmol, vol. 132, no. 2, pp. 142-149, 2014.
A. W. Heldman, DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., Mushtaq, M., Williams, A. R., Suncion, V. Y., McNiece, I. K., Ghersin, E., Soto, V., ,, Da Silva, J., Anderson, E., Schwarz, R., Mendizabal, A., and Hare, J. M., Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial, JAMA, vol. 311, pp. 62-73, 2014.
M. Horwitz, Chao, N., Rizzieri, D., Long, G., Sullivan, K., Gasparetto, C., Chute, J., Morris, A., McDonald, C., Waters-Pick, B., Stiff, P., Wease, S., Peled, A., Snyder, D., Cohen, E., Shoham, H., Landau, E., Friend, E., Peleg, I., ,, and Peled, T., Umbilical Cord Blood Expansion with Nicotinamide Provides Long-Term Multilineage Engraftment, J Clin Invest, vol. 124, pp. 3121-3128, 2014.